Merck

Combine

Pharma

Merck-Gilead first-of-its-kind combo pill scores in 2 HIV trials

A combo pill from Merck and Gilead has succeeded in two phase 3 trials and is set up to become the first oral HIV treatment that can be taken weekly.

Kevin Dunleavy Jun 9, 2026 11:20am

Berlin Germany Brandenburg Gate

Lilly, Boehringer slash investment plans in Germany

Jun 3, 2026 3:10pm

Imfinzi

AZ gains on Merck with 2nd bladder cancer nod for Imfinzi

May 28, 2026 4:39pm

Kelun

In endometrial cancer, Merck and Kelun score with sac-TMT

May 18, 2026 11:21am

Merck Co

Merck reports mixed results in Q1 for Winrevair, Ohtuvayre

Apr 30, 2026 11:40am

baseball field pitch inning

Merck bats for heart disease awareness

Apr 30, 2026 9:30am